Comparing Machine Guided VR Based Training With Educator Guided Training in Metaverse

Comparing Machine Guided VR Based Training With Educator Guided Training in Metaverse Environment: A Randomized Controlled Study

The main aim of this study is to compare the learning outcomes of machine guided VR based training for adult advanced life support with educator guided training in metaverse environment.

Study Overview

• Status: Recruiting
• Conditions: Virtual Reality; Serious Game; Advanced Cardiac Life Support
• Intervention / Treatment: Other: VR Based Training with Machine Guidance (MG Group); Other: VR Based Training with Educator Guidance in Metaverse (EG Group)

Detailed Description

Online education stands as one of the metaverse's potential application areas. The metaverse's ability to offer shared social connections differs it from existing online educational platforms such as Simulation, AR, and VR, which primarily focus on presenting virtual content and environments without fostering communal interaction. This facilitates interaction between learners and educators during metaverse-based training sessions allowing educators to guide the learners and provide feedback. The educators' presence fosters communication and collaboration during training sessions, thereby enhancing learners' motivation and engagement.

In our university, a VR-based multiplayer training module within the metaverse environment specifically designed for ALS (Adult Advanced Life Support) training has been developed. This module serves as an additional training tool to simulation-based training, enabling learners to receive guidance either from machine algorithms or educators within the metaverse. The objective of this study is to reveal the benefits of educator presence in the metaverse during VR-based training sessions.

• Study Type: Interventional
• Enrollment (Estimated): 62
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Mehmet Emin Aksoy, MD, Ph.D.; Phone Number: +905052685158; Email: emin.aksoy@acibadem.edu.tr
• Study Contact Backup: Name: Dilek Kitapcioglu, MD, Ph.D.; Phone Number: +905323636115; Email: dilek.kitapcioglu@acibadem.edu.tr

Study Locations

• Turkey
  • Non-US/Canada
    • Istanbul, Non-US/Canada, Turkey, 34752
      • Recruiting
      • Acibadem University CASE (Center of Advanced Simulation and Education)
      • Contact: Dilek Kitapcioglu, Assist.Prof; Phone Number: +905323636115; Email: dilek.kitapcioglu@acibadem.edu.tr
      • Contact: Mehmet Emin Aksoy, Assoc.Prof; Phone Number: +905052685158; Email: emin.aksoy@acibadem.edu.tr
      • Principal Investigator: Dilek Kitapcioglu, Assist.Prof
      • Principal Investigator: Mehmet Emin Aksoy, Assoc.Prof
      • Sub-Investigator: Arun Ekin Ozkan, M.Sc.
      • Sub-Investigator: Tuba Usseli, M.Sc.
    • Istanbul, Non-US/Canada, Turkey, 34752
      • Not yet recruiting
      • Acibadem University CASE (Center of Advanced Simulation and Education)
      • Sub-Investigator: Arun Ekin Ozkan, M.Sc.
      • Contact: Mehmet Emin Aksoy, Assoc.Prof; Phone Number: +902165004201; Email: emin.aksoy@acibadem.edu.tr
      • Contact: Dilek Kitapcioglu, Ph.D.; Phone Number: Aksoy +2165004202; Email: dilek.kitapcioglu@acibadem.edu.tr
      • Principal Investigator: Dilek Kitapcioglu, MD, Ph.D.
      • Principal Investigator: Mehmet Emin Aksoy, MD, Ph.D.
      • Sub-Investigator: Tuba Usseli, M.S

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Volunteering for the study

Exclusion Criteria:

• Previously experienced VR-induced motion sickness
• Previous Advanced Life Support training
• Other medical conditions like vertigo attacks
• Being under medication, which may cause vertigo like symptoms.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: MG Group; The group trained with VR Based Training with Machine Guidance will be referred as MG group.	Other: VR Based Training with Machine Guidance (MG Group); The members of both groups will undertake a VR based basic training for ALS. Afterwards MG group were trained with VR based Advanced Training Module, which provides training with full machine guidance. The knowledge level will then be evaluated by the exam mode of the VR based training module
Other: EG Group; The group trained with VR Based Training with Educators Guidance in Metaverse will be referred as EG group.	Other: VR Based Training with Educator Guidance in Metaverse (EG Group); The members of both groupswill undertake a VR based basic training for ALS. Afterwards EG group will attend at VR based Educator guided training in metaverse. The knowledge level will then be evaluated by the exam mode of the VR based training module

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Comparing Learning outcome of the Advanced Cardiac Life Support Training of the two interventions used in this study	Knowledge assessment will be conducted using the exam mode of the VR-based training module, evaluating users' performances utilizing an international algorithm developed by the American Heart Association (AHA) and Crisis Resource Management Criteria (CRM) derived from Aviation Training Algorithms. Seventy percent of the total performance score will be derived from ACLS assessments, with the remaining percentage calculated from CRM performances of the participants. The primary outcome of the study will be determined by the total score obtained through the exam mode of the VR-based training module.	The participants will complete the exam mode for final evaluation right after the completion of training on the same day

Collaborators and Investigators

• Sponsor: Acibadem University

Study record dates

Study Major Dates

• Study Start (Estimated): March 4, 2024
• Primary Completion (Estimated): March 29, 2024
• Study Completion (Estimated): April 11, 2024

Study Registration Dates

• First Submitted: February 14, 2024
• First Submitted That Met QC Criteria: February 28, 2024
• First Posted (Actual): March 1, 2024

Study Record Updates

• Last Update Posted (Actual): March 1, 2024
• Last Update Submitted That Met QC Criteria: February 28, 2024
• Last Verified: February 1, 2024

More Information

Terms related to this study

• Other Study ID Numbers: 2023-20/672

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: YES
• IPD Plan Description: Upon request by email.
• IPD Sharing Time Frame: 6 Months
• IPD Sharing Access Criteria: Upon request by email.
• IPD Sharing Supporting Information Type: STUDY_PROTOCOL; ICF

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No